Verana Health completed a $100m round led by existing investor GV that will help it expand its clinical database platform into new areas.
GV, a corporate venturing subsidiary of internet and technology group Alphabet, led a $100m funding round for US-based clinical data platform developer Verana Health yesterday.
Bain Capital Ventures, Casdin Capital and Define Ventures also took part in the round, as did unnamed existing shareholders.
Spun out of Oak Ridge National Laboratory in 2013, Verana has built a software platform that aggregates information from several clinical databases, such as the one maintained by the American Academy of Ophthalmology, and analyses the…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
